2026 NPPES data Otolaryngology/Facial Plastic Surgery Physician NPI 1215509468 PA-C
Verify on CMS →

SOPHIA LANGE, PA-C

Otolaryngology/Facial Plastic Surgery Physician in DALLAS, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
366
Medicare Part D claims · 155 beneficiaries · Otolaryngology/Facial Plastic Surgery Physician avg: 561
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$24.07
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SOPHIA LANGE, PA-C filed 366 Medicare Part D claims in 2023 as a Otolaryngology/Facial Plastic Surgery Physician in DALLAS, Texas, prescribing 93% generic.

366
Part D claims, 2023
93%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SOPHIA LANGE, PA-C's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

366 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

SOPHIA LANGE, PA-C practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SOPHIA LANGE, PA-C?

Quality data not reported

NPI registry status

Active

Issued 07/15/2021

NPI 1215509468

Primary specialty

Otolaryngology/Facial Plastic Surgery Physician

Niche

744 US NPIs in this specialty

Medicare Part D claims

366 35% vs specialty avg

2023 prescription claims

Specialty avg: 561

Specialty distribution in Texas

How Otolaryngology/Facial Plastic Surgery Physician compares to other specialties among Texas providers

Texas providers

Otolaryngology/Facial Plastic Surgery Physician share within Texas

1. Otolaryngology/Facial Plastic Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngology/Facial Plastic Surgery Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Otolaryngology/Facial Plastic Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Otolaryngology/Facial Plastic Surgery Physician ABMS/AOA estimate

Est. board-certified rate (Otolaryngology/Facial Plastic Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Otolaryngology/Facial Plastic Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SOPHIA LANGE, PA-C appears in the CMS NPPES registry as a Otolaryngology/Facial Plastic Surgery Physician provider holding PA-C credentials at 411 N WASHINGTON AVE STE 7000, DALLAS, TX, 75246, with a listed phone of (214) 826-3681. NPI 1215509468 was issued on 07/15/2021. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LANGE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 366 prescription claims written by this provider, covering 155 Medicare beneficiaries and totaling roughly $20K in drug spend, split 7% brand-name and 93% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Otolaryngology/Facial Plastic Surgery Physician is a narrow specialty nationwide, with 744 enrolled providers across 53 states and an average of 561 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

411 N WASHINGTON AVE STE 7000
DALLAS, TX 75246

Provider Details

NPI 1215509468
Specialty Otolaryngology/Facial Plastic Surgery Physician
Credentials PA-C
Gender Female
NPI Issued 07/15/2021

Hospital and facility affiliations

Facilities where SOPHIA LANGE, PA-C bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

EAR NOSE AND THROAT SPECIALTY CARE PLLC
DALLAS, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SOPHIA LANGE, PA-C. Source: openpaymentsdata.cms.gov.

Total received

$24

Largest payer

Atos Medical Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to SOPHIA LANGE, PA-C. To verify SOPHIA LANGE, PA-C's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

SOPHIA LANGE, PA-C — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 366 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

366
Total Claims
$20K
Total Drug Cost
155
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
424
Total Day Supply
8,023
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$3K
Generic Drug Cost
$16K
Antibiotic Claims
58

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
1.48
Gender Split
58% female / 42% male
Age Distribution
<65: 18, 65-74: 67, 75-84: 54, 85+: 16

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SOPHIA LANGE, PA-C prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Dexamethasone Sodium Phosphate
57
Azelastine Hcl
37
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
35
Prednisone
29
Ciprofloxacin-Dexamethasone
Ciprofloxacin Hcl/Dexameth
28
Omeprazole
28
Ofloxacin
26
Ipratropium Bromide
23
Hydrocortisone-Acetic Acid
Hydrocortisone/Acetic Acid
19
Acetic Acid
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngology/Facial Plastic Surgery Physician Overview

How SOPHIA LANGE, PA-C fits within the Otolaryngology/Facial Plastic Surgery Physician landscape nationally.

744
Otolaryngology/Facial Plastic Surgery Physician Providers in US
53
States with Otolaryngology/Facial Plastic Surgery Physician
561
Avg Claims per Provider

SOPHIA LANGE, PA-C's 366 claims are below the specialty average of 561.

Nearby Otolaryngology/Facial Plastic Surgery Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as LANGE.

Compare Otolaryngology/Facial Plastic Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SOPHIA LANGE, PA-C's specialty?
SOPHIA LANGE, PA-C specializes in Otolaryngology/Facial Plastic Surgery Physician and practices in DALLAS, Texas. Credentials: PA-C.
How much does SOPHIA LANGE, PA-C prescribe under Medicare Part D?
In 2023, SOPHIA LANGE, PA-C wrote 366 Medicare Part D claims totaling $20K in drug costs for 155 beneficiaries.
Where is SOPHIA LANGE, PA-C located?
SOPHIA LANGE, PA-C is located at 411 N WASHINGTON AVE STE 7000, DALLAS, TX, 75246. Phone: (214) 826-3681.
What is SOPHIA LANGE, PA-C's NPI number?
SOPHIA LANGE, PA-C's National Provider Identifier (NPI) is 1215509468, issued on 07/15/2021.
Does SOPHIA LANGE, PA-C prescribe more brand-name or generic drugs?
SOPHIA LANGE, PA-C's prescribing is 7% brand-name and 93% generic drugs by claim count, with $3K in brand drug costs.
How many Otolaryngology/Facial Plastic Surgery Physician providers are there in the US?
There are 744 Otolaryngology/Facial Plastic Surgery Physician providers across 53 states in the US. The average Otolaryngology/Facial Plastic Surgery Physician provider writes 561 Medicare Part D claims per year.
What drugs does SOPHIA LANGE, PA-C prescribe most often?
Based on 2023 Medicare Part D data, SOPHIA LANGE, PA-C's most frequently prescribed drugs include Dexamethasone Sodium Phosphate, Azelastine Hcl, Amoxicillin-Clavulanate Potass. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SOPHIA LANGE, PA-C accept Medicare?
SOPHIA LANGE, PA-C appears in CMS Medicare data with 366 Part D claims and 155 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SOPHIA LANGE, PA-C's credentials?
SOPHIA LANGE, PA-C's NPI is 1215509468 with credentials PA-C. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology